Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Disclaimer: All resources on this site are collected from the internet. If any content infringes on your rights, please contact us and we will remove it within 24 hours.
Like 
Dislike